Tumor infiltrating B cells and plasma cells influence early stage lung cancer #lungcancer #plasmacells #lungtumors #cancerresearch #immunotherapy #immuneresponse #cellres #cancerimmunotherapy #bcelldevelopment #cellmembranes #lungs #academicresearchers #discoveryresearch #tumorgrowth #cancerpatients #tumortissue #celldiffation #tumorcells Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma […]

Role of Hypersialylation in Multiple Myeloma Protection This video is a poster presentation contributing to our Virtual Cancer Conference 2020 and focuses on the effect of the hypersialylated Multiple Myeloma cell surface on NK cell-mediated immunosurveillance. Related and Helpful Resources Virtual Cancer Conference: CRISPR in Cancer Research: https://www.synthego.com/events/crispr-cancer-webinar-05-20-2020 CRISPR Cancer Research: https://www.synthego.com/crispr-cancer CAR T Therapy: […]

The role of non-antibody-based approaches to immunomodulation in multiple myeloma In this video, Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, comments on the role of non-antibody-based approaches in the treatment of multiple myeloma, highlighting the growing importance of IMiDs and CELMoDs.This interview took place at the 19th International Myeloma Society Meeting […]

Monday Morning Medical Update: New Treatment for Multiple Myeloma Plus: Kids and Screen Time The University of Kansas Health System is treating a total of 53 COVID patients today, up from 50 Friday. Other significant numbers: 36 with the active virus today, 26 Friday 6 in ICU, 6 Friday 2 on ventilators, 2 Friday 17 […]

MYELOMA and MULTIPLE MYELOMA – EVERYTHING YOU NEED TO KNOW | Cancer Education and Research Institute In this video we explain the basic informations you need to know about Myeloma and Multiple Myeloma. Myeloma is type of cancer that arise from immune system cells, called B cells (also known as Plasma cells), which normally produces […]

Phase I study of CART-ddBCMA in R/R multiple myeloma Matthew J. Frigault, MD, Harvard Medical School, Boston, MA, discusses the safety and efficacy results of a Phase I study of CART-ddBCMA, an autologous anti-BCMA CAR-T cell therapy that utilizes a novel, synthetic binding domain, called a D-Domain, instead of a typical scFv binder, in patients […]

Getting Clear Answers to Complex Treatment Challlenges in Multiple Myeloma Join us for a provocative program that includes interactive case discussions and a review of the data from a panel of renowned myeloma experts who will provide varied perspectives on new data, guideline changes, and expert recommendations for management of patients with multiple myeloma. Interact […]

PLASMA CELL DISORDERS PART 2: Lab Diagnosis of Multiple Myeloma in this short tutorial,i e part 2 of plasma cell disorders , i have discussed Lab diagnosis of multiple myeloma to know more about this topic click here https://ilovepathology.com/pathology-of-multiple-myeloma/ Click on website http://ilovepathology.com/ for more content for undergraduate students in pathology. Please feel free to […]

Understanding Multiple Myeloma Relapse Presented by Dr Ciara Freeman, Canadian myeloma expert.

My Cancer Relapse, Latest Treatments & Clinical Trials: Multiple Myeloma | Connie’s Story (2 of 3) Connie first noticed small bumps on her arms, light purple in color, but they were explained away by her doctors. Finally, they were growing fast enough for her to push for more examination. That’s when she learned the multiple […]